Stay updated with breaking news from James Cutrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The companies say they can quickly develop new omicron-targeting antibodies, but those aren't expected to launch for at least several months.
Omicron May Sideline Two Leading Drugs Against COVID-19.
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they've used to fight COVID-19
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they've used to fight COVID-19.
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases...